SOFIA (Bulgaria), November 10 (SeeNews) – Bulgarian drug producer Sopharma [BUL:3JR] said on Monday it has been cleared by the country's financial regulator to absorb its subsidiary Bulgarian Rose–Sevtopolis [BUL:4BJ].